Please provide your email address to receive an email when new articles are posted on . Guselkumab 200 mg every 4 weeks was more beneficial in patients with high disease activity and severity than 100 ...

Credit: Novo Nordisk Wegovy is a glucagon-like peptide-1 receptor agonist. The prescribing information for Wegovy (semaglutide) has been updated to include new information related to maintenance ...

Credit: Eisai and Biogen. The SC formulation is supplied as a 360mg/1.8mL single-dose prefilled autoinjector. To help support patients with at-home administration, Eisai and Biogen have launched the ...

Findings from DEVOTE support clinical benefits of the high-dose regimen of nusinersen (50 mg and 28 mg) in both ...

Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan ...

TORONTO -- An investigational subcutaneous autoinjector showed comparable efficacy and safety to the IV formulation of lecanemab (Leqembi) for maintenance treatment in early Alzheimer's disease, ...

With several anti-amyloid antibodies now proven to clear plaque from the human brain, researchers are turning their attention to fine-tuning immunotherapy for Alzheimer’s disease. At the 16th ...

Ultomiris (ravulizumab-cwvz) is a brand-name drug prescribed for certain autoimmune conditions. Ultomiris is given as an intravenous (IV) infusion by a healthcare professional. The drug’s dosing ...